SCHEMBL29618332

SCHEMBL29618332

N#Cc1ccc2c(c1)COC2C(F)(F)F

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PNMT P11086 6/20 0.44
PTGS2 P35354 1/20 0.40
P2RY6 Q15077 1/20 0.39
CHRNA1 P02708 1/20 0.36
CHRNG P07510 1/20 0.36
CHRNB1 P11230 1/20 0.36
CHRNB2 P17787 1/20 0.36
CHRNB4 P30926 1/20 0.36
CHRNA3 P32297 1/20 0.36
CHRNA4 P43681 1/20 0.36
CHRND Q07001 1/20 0.36
DRD2 P14416 2/20 0.35
DRD3 P35462 2/20 0.35
KIF11 P52732 1/20 0.33
AR P10275 4/20 0.33
TRPM5 Q9NZQ8 2/20 0.32
TRPM4 Q8TD43 1/20 0.32
CYP11B2 P19099 1/20 0.32
PRF1 P14222 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29618323 0.88 PNMT (0.44) PNMTPTGS2P2RY6CHRNA1CHRNG
SCHEMBL24517521 0.76 ADRA2A (0.41) PNMTP2RY6
SCHEMBL23481105 0.76 PNMT (0.41) PNMTCHRNA1CHRNGCHRNB1CHRNB2
SCHEMBL6808079 0.73 SLC6A4 (0.40) PNMTCHRNA1CHRNGCHRNB1CHRNB2
SCHEMBL14199799 0.72 FADS1 (0.40) DRD2DRD3TRPM5TRPM4
SCHEMBL22043585 0.72 FADS1 (0.40) DRD2DRD3TRPM5TRPM4
SCHEMBL1686 0.72 FADS1 (0.40) DRD2DRD3TRPM5TRPM4
SCHEMBL8899288 0.70 CHRNA1 (0.35) PNMTCHRNA1CHRNGCHRNB1CHRNB2
SCHEMBL8896169 0.70 KDM4E (0.36) PNMTCHRNA1CHRNGCHRNB1CHRNB2
SCHEMBL6810997 0.68 PPARA (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022121805-A1 FUSED RING COMPOUND AS NAV1.8 INHIBITOR AND USE THEREOF 成都康弘药业集团股份有限公司 2022-06-16 WO disclosed
CN-114591293-A Fused ring compound as Nav1.8 inhibitor and application thereof 成都康弘药业集团股份有限公司 2022-06-07 CN disclosed